HIT Consultant

OCTOBER 25, 2022

The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.

Pharmaceuticals 98

Pharmaceuticals Regulations Doctors Health Technology 98

HIT Consultant

JUNE 29, 2022

The Covid-19 pandemic has led to a surge in innovation across the life sciences industry, including vaccines and treatments being developed, approved, manufactured and delivered at an unprecedented scale in a matter of months – truly a remarkable achievement, and a testament to human ingenuity. About Annette Williams.

Regulations 98

Regulations Life Sciences Pharmaceuticals Accountability 98

Healthcare It News

OCTOBER 7, 2021

Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals. "This limited access to groundbreaking treatments and being part of the system of science to improve treatments for future patients is the other side of the problem." THE PROBLEM.

Life Sciences 276

Life Sciences Pharmaceuticals Regulations Health Data 276

HIT Consultant

MAY 18, 2023

What You Should Know: ArisGlobal , a provider of life sciences software acquires SPORIFY , the trusted substances, products, organizations and referentials (SPOR) data harmonization technology solution for five of the world’s top 20 largest pharmaceutical companies. Financial details of the acquisition were not disclosed.

Life Sciences 52

Life Sciences Pharmaceuticals Patient Safety Regulations 52

HIT Consultant

APRIL 6, 2022

Founded in 2019 by Harshit, a former physician who transitioned into the healthcare marketing space, Doceree empowers life sciences brands and media agencies with solutions that seamlessly reach HCPs on professional HCP networks and within their digital workflow to achieve better patient health outcomes. How It Works.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Healthcare 98

HIT Consultant

AUGUST 21, 2022

We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. The Center is responsible for researching, developing and operationalizing machine learning and data science solutions in the R&D business.

Life Sciences 97

Life Sciences Pharmaceuticals Patient Safety Regulations 97

Health Populi

JANUARY 10, 2024

Abbott, one of the first life science companies to exhibit at CES back in 2022, announced the HeartMates program here at #CES2024 today as part of a panel titled Ahead of the Game: Revolutionizing Athlete Safety with Emerging Health Tech. .”

Life Sciences 87

Life Sciences Regulations Home Care Prevention 87

Healthcare ECONOMIST

MAY 22, 2024

Many large and small pharmaceutical firms rely on contract manufacturers in China to actually make the drugs they have invented. Would current contracts that pharmaceutical firms have with these “companies of concern” be impacted? ” Bottom line, how much will this legislation cost life science companies?

Pharmaceuticals 56

Pharmaceuticals Life Sciences Regulations 56

HIT Consultant

FEBRUARY 1, 2024

Mike Szczesny, Owner & VP of EDCO Awards & Specialties Influencer marketing in the pharmaceutical industry is a complex issue with reasonable arguments on multiple sides. According to the FDA’s website , here are some regulations: Ads must be truthful.

Pharmaceuticals 111

Pharmaceuticals Regulations Doctors Prevention 111

Bill Of Health

AUGUST 6, 2021

However, since each disease affects less than one person in every 2,000, the pharmaceutical industry has traditionally been reluctant to invest in research and development connected to such illnesses given the small market. Orphan Drug Act 1983 and the EU Orphan Drug Regulation 2000) were enacted in an effort to incentivize innovation.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations 98

HIT Consultant

FEBRUARY 8, 2024

– Unlearn collaborates with pharmaceutical companies, biotechs, and academic institutions to optimize and streamline clinical trials. This investment, bringing Unlearn’s total funding to over $130M, will fuel its mission to eliminate trial and error in medicine through faster, smaller, and more ethical clinical trials.

Pharmaceuticals 97

Pharmaceuticals Regulations Life Sciences 97

HIT Consultant

JANUARY 30, 2024

a pioneer in epigenomic technologies, today unveiled an alliance through which Personalis will expand its pharmaceutical service offerings by distributing ClearNote’s cutting-edge epigenomic 5-hydroxymethylcytosine (5hmC) platform. What You Should Know: Personalis, Inc. , a leader in advanced genomics for cancer, and ClearNote Health, Inc. ,

Pharmaceuticals 96

Pharmaceuticals Regulations Life Sciences 96

Healthcare ECONOMIST

DECEMBER 28, 2022

 In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.

Life Sciences 71

Life Sciences Pharmaceuticals Medical Technology Regulations 71

HIT Consultant

NOVEMBER 6, 2023

Sooner or later, IoMT certification or regulation is coming Medical device manufacturers should anticipate more government mandates designed to enforce uniform and effective cybersecurity standards across consumer and hospital-grade IoMT solutions. Previously, he worked on IoT analytics and security solutions at Symantec.

Healthcare 111

Healthcare Life Sciences Pharmaceuticals Regulations 111

HIT Consultant

NOVEMBER 8, 2022

And given the fact that prescription drug prices continue to increase, the topic of drug price management is likely to continue to capture the attention of the media and policymakers at the state level, given the current lack of overriding federal regulation. What Can Pharmaceutical Companies Do to Stay Compliant?

Pharmaceuticals 52

Pharmaceuticals Life Sciences Law Firms Regulations 52

HIT Consultant

JUNE 25, 2024

However, while omnichannel is far from being simple in any industry, it raises unique challenges in the pharmaceutical industry. Some of these challenges stem from the nature of sales and marketing in pharma, where others stem from data limitations, process characteristics and regulations.

Regulations 96

Regulations Pharmaceuticals Integration Life Sciences 96

HIT Consultant

DECEMBER 19, 2023

Gary Shorter – Head, AI and Data Science, IQVIA Technologies In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.

Pharmaceuticals 105

Pharmaceuticals Quality Control Process improvement Integration 105

HIT Consultant

APRIL 23, 2024

What You Should Know: – Deciphex , a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis , a prominent multinational pharmaceutical corporation.

Pharmaceuticals 64

Pharmaceuticals Regulations Life Sciences Healthcare 64

HIT Consultant

JULY 25, 2022

Lauren Ohlsson, Lead of Industry Solutions, Pharmaceutical and Healthcare, at VDX.tv. Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media. . About Lauren Ohlsson.

Pharmaceuticals 98

Pharmaceuticals Accountability Regulations Integration 98

HIT Consultant

JANUARY 24, 2022

These and other questions are compelling us, as AI practitioners, to think differently in terms of how we can best advance clinical research and precision medicine using responsible AI that benefits patients, providers, payers, pharmaceutical companies and medical care professionals while avoiding unintended consequences, including bias.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Doctors 98

HIT Consultant

JUNE 18, 2024

What You Should Know: – Mika Health , a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called “UNITE” alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo. AI-powered recommendations: Tailored suggestions based on individual needs.

Pharmaceuticals 52

Pharmaceuticals Regulations Accountability Life Sciences 52

Bill Of Health

DECEMBER 8, 2023

Attorney Gene Quinn offers the most dramatic interpretation, calling the Supreme Court’s embrace of full scope enablement in Amgen “a cataclysmic shift in the law of enablement,” not just for antibodies but for “the life sciences community and beyond.”

Biotechnology 52

Biotechnology Life Sciences Pharmaceuticals Regulations 52

HIT Consultant

OCTOBER 16, 2023

While pharmaceutical companies are bound by rigorous standards and regulations, independent influencers are not held to the same criteria. Therefore, consultation with a healthcare provider is critical for anyone considering Ozempic for weight loss.

Doctors 98

Doctors Pharmaceuticals Regulations Healthcare Providers 98

Health Populi

JUNE 24, 2021

The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape , delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups.

Healthcare 108

Healthcare Pharmaceuticals Population Health Regulations 108

Health Advances

JULY 14, 2022

But we expect to see a change, with some traditional 361 CTPs taking the leap (willingly or unwillingly) into Biologics License Application (BLA) territory as well as innovators turning to development of products that can be considered pharmaceuticals.

Pharmaceuticals 52

Pharmaceuticals Regulations Healthcare Life Sciences 52

Health Advances

SEPTEMBER 15, 2020

New York’s NASDAQ is home to the most biotech companies in the world and remains the exchange with the longest history, highest degree of international exposure, and considerable depth of companies in the broader life sciences sector. Nevertheless, HKEX has remained a top destination for Chinese biotechs over the past two years.

Pharmaceuticals 98

Pharmaceuticals Biotechnology Life Sciences Healthcare 98

Health Populi

APRIL 24, 2019

Given tone and tenor of the day, and particularly among mass population, healthcare may continue to see increasing demands for change and regulation,” Susan Isenberg, Edelman’s head of healthcare, notes in her observations of the 2019 Edelman Trust Barometer.

Healthcare 83

Healthcare Life Sciences Hospitals Pharmaceuticals 83

HIT Consultant

DECEMBER 14, 2022

It’s a complex world filled with regulations and many layers of stakeholders. We don’t need to get into the intricacies of pharmacy benefit managers (PBMs) and reimbursements to understand the innovation underway in the pharmaceutical space. “Healthcare is hard,” he sighed. Cuban isn’t wrong. Healthcare is hard.

Patient Experience 98

Patient Experience Nursing Pharmaceuticals Healthcare 98

Health Populi

JUNE 29, 2021

consumers’ bipartisan support for drug price regulation through Medicare negotiation and private/commercial sector adoption. In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s discussion, covering: The macro- and micro-economics of Alzheimer’s and the $56,000 list price for the drug.

Medicare 62

Medicare Regulations Life Sciences Pharmaceuticals 62

HIT Consultant

MAY 31, 2023

The pharmaceutical industry has experienced a wave of accelerated consolidation since 2010. In 2019, the industry saw a record-breaking 1,276 pharmaceutical M&A’s , representing a total value surpassing $411 billion. In 2017, only four companies were responsible for 50% of generic pharmaceutical drug production.

Pharmaceuticals 96

Pharmaceuticals Healthcare Healthcare Innovation Telemedicine 96

HIT Consultant

JUNE 7, 2023

Kayt Leonard, Global Health Care and Life Sciences Strategic Advisor at SAS We hear it every day, right? Rising cost pressures from insurance companies, regulations aimed at reducing costs , and a generally complex and fragmented payment system can limit innovations that could improve patient outcomes. questionable.

Life Sciences 52

Life Sciences Healthcare Doctors Pharmaceuticals 52

HIT Consultant

OCTOBER 5, 2022

For pharmaceutical manufacturing firms, the amount of documentation required around state price transparency regulations continues to expand. Federal regulations are a long way off, and state-by-state reporting requirements are no longer “cut and paste” affairs that can be satisfied with a canned set of reports.

Regulations 52

Regulations Life Sciences Pharmaceuticals Medicaid 52

Health Populi

OCTOBER 8, 2019

Pricing failure, the second big waste factor, is predominantly challenged by pharmaceutical/prescription drug pricing based on this research. More savings would accrue through the quicker adoption of value-based payment models, the authors assert, where clinicians take on financial risk for managing population health.

Pharmaceuticals 108

Pharmaceuticals Life Sciences Medicare Accountability 108

HIT Consultant

NOVEMBER 2, 2022

The European Union (EU) has announced guidance on the Identification of Medicinal Product (IDMP) — and pharmaceutical companies around the world should take notice. It’s imperative that companies begin evaluating what changes need to be implemented, and the sooner pharmaceutical companies act, the better. This is no small feat.

Pharmaceuticals 52

Pharmaceuticals Life Sciences Integration Regulations 52

HIT Consultant

MAY 2, 2024

With AWS’s backing, Yseop aims to empower leading Biopharma companies globally, facilitating the expedited delivery of pharmaceuticals and vaccines to market. Crucially, AWS provides Yseop and its clientele with a fully managed, private cloud environment, crucial for compliance within the regulated life science industry.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Integration 98

HIT Consultant

JANUARY 13, 2022

Jon-Michael Smith, Head of Healthcare & Life Science Analytics – Data Integration at Qlik. Smith is the Head of Healthcare & Life Science Analytics – Data Integration at Qlik. About Jon-Michael P. Jon-Michael P.

Healthcare Analytics 52

Healthcare Analytics Health Data Life Sciences Healthcare 52

Sheppard Health Law

AUGUST 20, 2021

California Life Sciences Ass’n v. Ca); Regeneron Pharmaceuticals v. 2] California Life Sciences Ass’n v. FOOTNOTES. [1] 1] Association of Community Cancer Centers v. 8:20–cv–03531 (D. 3:20–cv–08603 (N.D. 7:20–cv–10488 (S.D.N.Y.); and Community Oncology Alliance, Inc. 3:20–cv–08603 (N.D.

Life Sciences 52

Life Sciences Medicare Pharmaceuticals Quality of Care 52